Chimeric clotting factors
US-2015353911-A1 · Dec 10, 2015 · US
US9644197B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9644197-B2 |
| Application number | US-201113701333-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 7, 2011 |
| Priority date | Jun 4, 2010 |
| Publication date | May 9, 2017 |
| Grant date | May 9, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A fusion protein comprising factor VII (FVII) and transferrin according to the present invention has an improved specific activity of FVII compared to existing FVII fusion proteins comprising other fusion partners than transferrin, and thus can be effectively used in a therapy using FVII.
Opening claim text (preview).
The invention claimed is: 1. A fusion protein comprising factor VII (FVII) and transferrin, wherein said transferrin is linked to the C-terminus of said FVII, and which further comprises a linker between the FVII and the transferrin, and one or more amino acids translated from a restriction enzyme recognition sequence between said C-terminus of said FVII and said transferrin; and wherein the linker comprises a protease cleavage site, which is capable of being cleaved by a protease selected from the group consisting of thrombin, factor Xa, factor IXa, and factor VIIa. 2. The fusion protein of claim 1 , wherein said FVII is a polypeptide represented by the amino acid sequence of SEQ ID NO: 1. 3. The fusion protein of claim 1 , wherein said transferrin is a polypeptide represented by the amino acid sequence of SEQ ID NO: 2. 4. The fusion protein of claim 1 , wherein the linker consists of 1 to 100 amino acids. 5. The fusion protein of claim 1 , wherein the linker consists of 1 to 75 amino acids. 6. The fusion protein of claim 1 , wherein the linker consists of 5 to 25 amino acids. 7. The fusion protein of claim 1 , wherein one or more amino acids translated from the restriction enzyme recognition site are present at one end or both ends of the linker. 8. The fusion protein of claim 1 , wherein the linker is a peptide represented by any one of the amino acid sequences of SEQ ID NOs: 3 to 11.
Coagulation factor VIIa (3.4.21.21) · CPC title
Platelet-derived growth factor [PDGF] · CPC title
Fusion polypeptide · CPC title
fusions, other than Fc, for prolonged plasma life, e.g. albumin · CPC title
Coagulation factor VIIa (3.4.21.21) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.